BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Boehringer Ingelheim
Fuji
Covington
Deloitte
Daiichi Sankyo
Farmers Insurance
US Department of Justice
Cantor Fitzgerald

Generated: January 17, 2018

DrugPatentWatch Database Preview

LIPO-HEPIN Drug Profile

« Back to Dashboard

When do Lipo-hepin patents expire, and what generic alternatives are available?

Lipo-hepin is a drug marketed by 3M and is included in one NDA.

The generic ingredient in LIPO-HEPIN is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for LIPO-HEPIN
Drug patent expirations by year for LIPO-HEPIN

US Patents and Regulatory Information for LIPO-HEPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m LIPO-HEPIN heparin sodium INJECTABLE;INJECTION 017027-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m LIPO-HEPIN heparin sodium INJECTABLE;INJECTION 017027-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m LIPO-HEPIN heparin sodium INJECTABLE;INJECTION 017027-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m LIPO-HEPIN heparin sodium INJECTABLE;INJECTION 017027-011 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m LIPO-HEPIN heparin sodium INJECTABLE;INJECTION 017027-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m LIPO-HEPIN heparin sodium INJECTABLE;INJECTION 017027-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m LIPO-HEPIN heparin sodium INJECTABLE;INJECTION 017027-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m LIPO-HEPIN heparin sodium INJECTABLE;INJECTION 017027-010 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m LIPO-HEPIN heparin sodium INJECTABLE;INJECTION 017027-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m LIPO-HEPIN heparin sodium INJECTABLE;INJECTION 017027-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Baxter
Chinese Patent Office
Cerilliant
Cantor Fitzgerald
Johnson and Johnson
Covington
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot